Mesothelioma|Treatment Options|Asbestos Exposure|Veterans And Mesothelioma|News

2005

Combination of Cisplatin and Raltitrexed Improves Survival with Mesothelioma

New Haven, Connecticut - October 5, 2005

According to the results of a phase III clinical trial published in the Journal of Clinical Oncology, treatment with both cisplatin and raltitrexed results in better survival among patients with malignant pleural mesothelioma than treatment with cisplatin alone.

U.S. Asbestos Fund Would Quickly go Broke -- Study

Washington, D.C. - September 19, 2005

A $140 billion asbestos compensation fund being considered in the U.S. Senate would be swamped by more than double that amount in claims and go broke within three years, according to a study released on Monday...

Fujirebio Diagnostics Expands Commercial Availability of First Blood Test for Mesothelioma

Malvern, Pennsylvania - April 14, 2005

Fujirebio Diagnostics, Inc. (FDI), a world-leader in oncology testing, and Cisbio international, a French biotechnology company, today announced a distribution agreement for European distribution of FDI's new blood test for mesothelioma - MESOMARK(TM).

SV40 not implicated in Mesothelioma

New York, New York - April 10, 2005

New highly sensitive approach shows no evidence of SV40 in tumors - SV40 unlikely to be factor in asbestos related cancers...

Last modified: March 17 2010

If you have any questions regarding your legal rights, please contact us.
New York Office  360 Lexington Ave., 20th Floor  New York, New York, 10017  (P): 212-986-2233  (F): 212-986-2255
New Haven Office  One Century Tower, 265 Church Street  New Haven, CT 06508-1866  (P): 203-777-7799  (F): 203-785-1671

Copyright © 2010 by James F. Early LLC. All Rights Reserved. Attorney Advertising.

Thank you for visiting this website which is created for the benefit of the general public. This website and its content are produced and sponsored by the law firm of James F. Early, LLC (James F. Early, Esq.). This website is devoted to the needs of people diagnosed with mesothelioma; nonetheless it may be considered attorney advertising. The content contained herein was not prepared by medical professionals and it is not intended, nor should it be considered, as a substitute for medical advice. The information provided on this website is intended as educational material, designed solely to support, and not replace, the relationship that exists between a patient/site visitor and his/her healthcare professional. Additionally, neither visiting this website nor viewing its content is intended, and shall not be considered, to create an attorney-client relationship. An attorney-client relationship can only be created by mutual agreement and consent of the prospective client and the attorney. Neither the transmission nor receipt of this website material will create an attorney-client relationship between sender and receiver. The material contained herein is general in nature and may not apply to your particular factual or legal circumstances. Online readers should not act on this information without seeking professional counsel and advice. Please read our disclaimer for more information.